CN Patent

CN103459399A — 用于治疗丙型肝炎病毒感染的四环吲哚衍生物

Assigned to Merck Sharp and Dohme LLC · Expires 2013-12-18 · 12y expired

What this patent protects

提供了式(I)的四环吲哚衍生物、其药学上可接受的盐和药物组合物，其中A、A’、G、R 1 、R 15 、U、V、V、W、W、X、X’、Y、Y’如本发明中所定义。也提供了这些衍生物在治疗丙型肝炎病毒(HCV)感染中的用途。

USPTO Abstract

提供了式(I)的四环吲哚衍生物、其药学上可接受的盐和药物组合物，其中A、A’、G、R 1 、R 15 、U、V、V、W、W、X、X’、Y、Y’如本发明中所定义。也提供了这些衍生物在治疗丙型肝炎病毒(HCV)感染中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103459399A
Jurisdiction
CN
Classification
—
Expires
2013-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.